Please provide your email address to receive an email when new articles are posted on . In an observational cohort study, researchers examined Medicare beneficiaries who recently started using an AV ...

Xeltis BV plans to expedite an international pivotal trial investigating its restorative hemodialysis access graft Axess following encouraging preliminary data. The company released results from a ...

In our practice, a commitment to autologous access began even before the publication of the DOQI guidelines. Early in our experience, prosthetic grafts were generally the third line of intervention ...

A phase 2 trial of patients receiving hemodialysis via an arteriovenous graft found no benefit from a factor XI inhibitor. The monoclonal antibody MK-2060 does not meaningfully lower arteriovenous ...